Great point...and no, I don't. I also don't think AXON's MC should be 10x the other small biotech (AV__) with positive AD results (another AF target). I wonder why all of a sudden AF has such interest in an OTC company that was recently attacked by Mako with complete nonsense....it is way too coincidental to be just AF looking out for investors. What I want to see is if Rosen or other firms pipe up based upon the AF article....I bet they don't!